1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Zhang, Y. Swietnicki, W. Zagorski, M.G. Surewicz, W.K. Soennichsen, F.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 275 33650 33654 10.1074/jbc.C000483200 10954699 Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases. 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 16169.063 PRION PROTEIN PRP(90-231) E200K 1 man polymer no no GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEY SNQNNFVHDCVNITIKQHTVTTTTKGENFTKTDVKMMERVVEQMCITQYERESQAYYQRGSS GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEY SNQNNFVHDCVNITIKQHTVTTTTKGENFTKTDVKMMERVVEQMCITQYERESQAYYQRGSS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample BRAIN 9606 BRAIN Homo sapiens 562 Escherichia coli PLASMID PET3 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2000-09-21 1 1 2007-10-21 1 2 2011-07-13 1 3 2018-03-14 _struct_ref_seq_dif.details RCSB Y RCSB 2000-08-09 REL The structure was determined using triple-resonance NMR spectroscopy. structures with the lowest energy 60 1 3D_13C-separated_NOESY 3D_15N-separated_NOESY 0.00001 4.6 1 atm 299 K simulated annealing molecular dynamics 11 lowest energy 0.8 mM E200K(90-231)PrP U-15N,13C; 10mM acetate buffer 90% H2O/10% D2O Brunger structure solution CNS 0.9 Nigles structure solution ARIA 0.9 Brunger refinement CNS 0.9 800 Bruker DRX 600 Varian INOVA n 1 90 A n 2 91 A n 3 92 A n 4 93 A n 5 94 A n 6 95 A n 7 96 A n 8 97 A n 9 98 A n 10 99 A n 11 100 A n 12 101 A n 13 102 A n 14 103 A n 15 104 A n 16 105 A n 17 106 A n 18 107 A n 19 108 A n 20 109 A n 21 110 A n 22 111 A n 23 112 A n 24 113 A n 25 114 A n 26 115 A n 27 116 A n 28 117 A n 29 118 A n 30 119 A n 31 120 A n 32 121 A n 33 122 A n 34 123 A n 35 124 A LEU 125 n 36 LEU 125 A GLY 126 n 37 GLY 126 A GLY 127 n 38 GLY 127 A TYR 128 n 39 TYR 128 A MET 129 n 40 MET 129 A LEU 130 n 41 LEU 130 A GLY 131 n 42 GLY 131 A SER 132 n 43 SER 132 A ALA 133 n 44 ALA 133 A MET 134 n 45 MET 134 A SER 135 n 46 SER 135 A ARG 136 n 47 ARG 136 A PRO 137 n 48 PRO 137 A ILE 138 n 49 ILE 138 A ILE 139 n 50 ILE 139 A HIS 140 n 51 HIS 140 A PHE 141 n 52 PHE 141 A GLY 142 n 53 GLY 142 A SER 143 n 54 SER 143 A ASP 144 n 55 ASP 144 A TYR 145 n 56 TYR 145 A GLU 146 n 57 GLU 146 A ASP 147 n 58 ASP 147 A ARG 148 n 59 ARG 148 A TYR 149 n 60 TYR 149 A TYR 150 n 61 TYR 150 A ARG 151 n 62 ARG 151 A GLU 152 n 63 GLU 152 A ASN 153 n 64 ASN 153 A MET 154 n 65 MET 154 A HIS 155 n 66 HIS 155 A ARG 156 n 67 ARG 156 A TYR 157 n 68 TYR 157 A PRO 158 n 69 PRO 158 A ASN 159 n 70 ASN 159 A GLN 160 n 71 GLN 160 A VAL 161 n 72 VAL 161 A TYR 162 n 73 TYR 162 A TYR 163 n 74 TYR 163 A ARG 164 n 75 ARG 164 A PRO 165 n 76 PRO 165 A MET 166 n 77 MET 166 A ASP 167 n 78 ASP 167 A GLU 168 n 79 GLU 168 A TYR 169 n 80 TYR 169 A SER 170 n 81 SER 170 A ASN 171 n 82 ASN 171 A GLN 172 n 83 GLN 172 A ASN 173 n 84 ASN 173 A ASN 174 n 85 ASN 174 A PHE 175 n 86 PHE 175 A VAL 176 n 87 VAL 176 A HIS 177 n 88 HIS 177 A ASP 178 n 89 ASP 178 A CYS 179 n 90 CYS 179 A VAL 180 n 91 VAL 180 A ASN 181 n 92 ASN 181 A ILE 182 n 93 ILE 182 A THR 183 n 94 THR 183 A ILE 184 n 95 ILE 184 A LYS 185 n 96 LYS 185 A GLN 186 n 97 GLN 186 A HIS 187 n 98 HIS 187 A THR 188 n 99 THR 188 A VAL 189 n 100 VAL 189 A THR 190 n 101 THR 190 A THR 191 n 102 THR 191 A THR 192 n 103 THR 192 A THR 193 n 104 THR 193 A LYS 194 n 105 LYS 194 A GLY 195 n 106 GLY 195 A GLU 196 n 107 GLU 196 A ASN 197 n 108 ASN 197 A PHE 198 n 109 PHE 198 A THR 199 n 110 THR 199 A LYS 200 n 111 LYS 200 A THR 201 n 112 THR 201 A ASP 202 n 113 ASP 202 A VAL 203 n 114 VAL 203 A LYS 204 n 115 LYS 204 A MET 205 n 116 MET 205 A MET 206 n 117 MET 206 A GLU 207 n 118 GLU 207 A ARG 208 n 119 ARG 208 A VAL 209 n 120 VAL 209 A VAL 210 n 121 VAL 210 A GLU 211 n 122 GLU 211 A GLN 212 n 123 GLN 212 A MET 213 n 124 MET 213 A CYS 214 n 125 CYS 214 A ILE 215 n 126 ILE 215 A THR 216 n 127 THR 216 A GLN 217 n 128 GLN 217 A TYR 218 n 129 TYR 218 A GLU 219 n 130 GLU 219 A ARG 220 n 131 ARG 220 A GLU 221 n 132 GLU 221 A SER 222 n 133 SER 222 A GLN 223 n 134 GLN 223 A ALA 224 n 135 ALA 224 A TYR 225 n 136 TYR 225 A TYR 226 n 137 TYR 226 A GLN 227 n 138 GLN 227 A ARG 228 n 139 ARG 228 A GLY 229 n 140 GLY 229 A SER 230 n 141 SER 230 A SER 231 n 142 SER 231 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLY 131 A N GLY 42 A O VAL 161 A O VAL 72 1 A GLY 90 A GLY 1 1 Y 1 A GLN 91 A GLN 2 1 Y 1 A GLY 92 A GLY 3 1 Y 1 A GLY 93 A GLY 4 1 Y 1 A GLY 94 A GLY 5 1 Y 1 A THR 95 A THR 6 1 Y 1 A HIS 96 A HIS 7 1 Y 1 A SER 97 A SER 8 1 Y 1 A GLN 98 A GLN 9 1 Y 1 A TRP 99 A TRP 10 1 Y 1 A ASN 100 A ASN 11 1 Y 1 A LYS 101 A LYS 12 1 Y 1 A PRO 102 A PRO 13 1 Y 1 A SER 103 A SER 14 1 Y 1 A LYS 104 A LYS 15 1 Y 1 A PRO 105 A PRO 16 1 Y 1 A LYS 106 A LYS 17 1 Y 1 A THR 107 A THR 18 1 Y 1 A ASN 108 A ASN 19 1 Y 1 A MET 109 A MET 20 1 Y 1 A LYS 110 A LYS 21 1 Y 1 A HIS 111 A HIS 22 1 Y 1 A MET 112 A MET 23 1 Y 1 A ALA 113 A ALA 24 1 Y 1 A GLY 114 A GLY 25 1 Y 1 A ALA 115 A ALA 26 1 Y 1 A ALA 116 A ALA 27 1 Y 1 A ALA 117 A ALA 28 1 Y 1 A ALA 118 A ALA 29 1 Y 1 A GLY 119 A GLY 30 1 Y 1 A ALA 120 A ALA 31 1 Y 1 A VAL 121 A VAL 32 1 Y 1 A VAL 122 A VAL 33 1 Y 1 A GLY 123 A GLY 34 1 Y 1 A GLY 124 A GLY 35 1 Y 1 A SER 132 -52.92 172.00 1 A MET 134 -130.63 -71.03 1 A PHE 141 -99.71 -93.00 1 A SER 143 -148.65 -154.30 1 A ASP 167 -105.55 -157.65 1 A TYR 169 55.24 74.06 HUMAN PRION PROTEIN (MUTANT E200K) HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 1 N N A SER 143 A SER 54 HELX_P A MET 154 A MET 65 1 1 12 A HIS 155 A HIS 66 HELX_P A TYR 157 A TYR 68 5 2 3 A ASN 171 A ASN 82 HELX_P A GLY 195 A GLY 106 1 3 25 A THR 199 A THR 110 HELX_P A GLY 229 A GLY 140 1 4 31 disulf 2.030 A CYS 179 A SG CYS 90 1_555 A CYS 214 A SG CYS 125 1_555 MEMBRANE PROTEIN three helix, CREUTZFELDT-JAKOB DISEASE, PRION, AGGREGATION, MEMBRANE PROTEIN PRIO_HUMAN UNP 1 P04156 90 231 1FKC 90 231 P04156 A 1 1 142 1 GLU ENGINEERED MUTATION LYS 200 1FKC A P04156 UNP 200 111 2 anti-parallel A MET 129 A MET 40 A GLY 131 A GLY 42 A VAL 161 A VAL 72 A TYR 163 A TYR 74 1 P 1